UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
________________________
 
FORM 8-K/A
AMENDMENT NO. 1
  _______________________
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):   November 30, 2016
 
 
 
 
OrangeHook, Inc.
(Exact name of Registrant as Specified in its Charter)
 
  Florida
000-54249
27-1230588
  (State or Other Jurisdiction of Incorporation
or Organization) 
(Commission file number)
(I.R.S. Employer Identification Number)
 
 
319 Barry Avenue South #300
Wayzata, Minnesota 55391
 (Address of Principal Executive Offices including Zip Code)
 
(442) 500-4665
(Registrant’s Telephone Number, including Area Code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 

 
 
 
 
 

EXPLANATORY NOTE
On December 5, 2016, OrangeHook, Inc., a Florida corporation formerly known as Nuvel Holdings, Inc. (the " Company "), filed a Current Report on Form 8-K (the " Initial Form 8-K ") that included an exhibit for which confidential treatment was requested from the Securities and Exchange Commission. The sole purpose of this amendment is to refile Exhibit 10.44, for which confidential treatment was requested, to include certain information that was previously redacted pursuant to the confidential treatment request. Exhibit 10.44 hereto supersedes in its entirety Exhibit 10.44 previously filed with the Initial Form 8-K. Other than disclosing certain information that was previously redacted, the exhibit filed with this Form 8-K/A remains unchanged from the exhibit filed with the Initial Form 8-K.
Item 9.01.
 
Financial Statements and Exhibits
 
(d)
 
The following exhibits are filed as a part of this Report.
 
Exhibit No.
 
Description
     
10.44
 
 
 
*
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Exchange Act. The entire exhibit has been separately filed with the Securities and Exchange Commission.
 
 
 
 
 
 
 
 
 
- 2 -

 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
ORANGEHOOK, INC.
 
 
 
 
Dated:   April 11, 2017
By:    /s/    James L. Mandel                                                                  
               James L. Mandel
               President and Chief Executive Officer
 
 
 
 
 
 
 
 

 
- 3 -

 
 
 
 
 
 
Exhibit Index
 
 
Exhibit No.
 
Description
     
10.44
 
 
 
*
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Exchange Act. The entire exhibit has been separately filed with the Securities and Exchange Commission.
 
 
 
 
 
 
 
 
 
- 4 -